Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study.

Gynecologic oncology - 1 Sept 2021

Safra Tamar, Waissengrin Barliz, Gerber Deanna, Bernstein-Molho Rinat, Klorin Geula, Salman Lina, Josephy Dana, Chen-Shtoyerman Rakefet, Bruchim Ilan, Frey Melissa K, Pothuri Bhavana, Muggia Franco

Abstract excerpt

OBJECTIVES: We evaluated the incidence of breast cancer and overall survival in a multi-center cohort of ovarian cancer patients carrying BRCA1/2 mutations in order to assess risks and formulate optimal preventive interventions and/or surveillance. METHODS: Medical records of 502 BRCA1/2 mutation carriers diagnosed with ovarian cancer between 2000 and 2018 at 7 medical centers in Israel and one in New York were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Incidence

Share to Kaplan-Meier Estimate

Share to Longitudinal Studies

Share to Ovarian Neoplasms

Share to Risk Assessment

Source

Identifiers

PMID: 34172288
DOI: 10.1016/j.ygyno.2021.06.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study.PMID 34172288Read ↗

Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers.Semantic proximity Read ↗

Breast cancer following ovarian cancer in BRCA mutation carriers.Semantic proximity Read ↗

Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation.Semantic proximity Read ↗

Breast cancer surveillance following ovarian cancer in BRCA mutation carriers.Semantic proximity Read ↗

Managing hereditary breast cancer risk in women with and without ovarian cancer.Semantic proximity Read ↗

Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.Semantic proximity Read ↗

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.Semantic proximity Read ↗

Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer.Semantic proximity Read ↗

[Clinical and familial characterisation of ovarian cancer patients with germline mutations in the BRCA1/2 gene and the current status of prevention in high-risk groups].Semantic proximity Read ↗

Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant.Semantic proximity Read ↗

The challenging screen detection of ovarian cancer in BRCA mutation carriers adhering to a 6-month follow-up program: results from a 6-years surveillance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.